Healthpeak Properties, Inc. $DOC Position Trimmed by Legal & General Group Plc

Legal & General Group Plc trimmed its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 27.3% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,190,236 shares of the real estate investment trust’s stock after selling 3,079,490 shares during the quarter. Legal & General Group Plc’s holdings in Healthpeak Properties were worth $143,411,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in the stock. Deutsche Bank AG grew its holdings in shares of Healthpeak Properties by 0.3% during the 1st quarter. Deutsche Bank AG now owns 8,482,898 shares of the real estate investment trust’s stock valued at $171,524,000 after acquiring an additional 23,136 shares in the last quarter. LPL Financial LLC boosted its position in Healthpeak Properties by 11.1% during the first quarter. LPL Financial LLC now owns 4,032,779 shares of the real estate investment trust’s stock valued at $81,543,000 after purchasing an additional 404,372 shares during the last quarter. Adelante Capital Management LLC grew its stake in Healthpeak Properties by 4,464.2% in the first quarter. Adelante Capital Management LLC now owns 1,189,069 shares of the real estate investment trust’s stock valued at $24,043,000 after purchasing an additional 1,163,017 shares in the last quarter. Aviva PLC increased its position in Healthpeak Properties by 6.6% in the 2nd quarter. Aviva PLC now owns 593,721 shares of the real estate investment trust’s stock worth $10,396,000 after purchasing an additional 36,603 shares during the last quarter. Finally, Alan B Lancz & Associates Inc. purchased a new stake in shares of Healthpeak Properties during the 2nd quarter worth about $373,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Trading Up 0.1%

NYSE:DOC opened at $17.87 on Tuesday. The company’s 50 day moving average is $18.28 and its 200-day moving average is $17.84. The company has a quick ratio of 1.28, a current ratio of 1.22 and a debt-to-equity ratio of 1.11. Healthpeak Properties, Inc. has a 12 month low of $16.63 and a 12 month high of $22.71. The firm has a market cap of $12.42 billion, a price-to-earnings ratio of -357.23, a P/E/G ratio of 3.84 and a beta of 1.10.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.01. The business had revenue of $705.87 million for the quarter, compared to analyst estimates of $681.65 million. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. Healthpeak Properties’s revenue was up .8% compared to the same quarter last year. During the same period last year, the business posted $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 19th will be paid a $0.1017 dividend. The ex-dividend date is Friday, December 19th. This represents a c) dividend on an annualized basis and a dividend yield of 6.8%. Healthpeak Properties’s payout ratio is presently -2,440.00%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Robert W. Baird lowered their price target on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a research note on Wednesday, November 12th. Raymond James Financial upgraded shares of Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research note on Monday, September 15th. Wells Fargo & Company dropped their price target on shares of Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 27th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $18.00 price target (down previously from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Finally, Morgan Stanley decreased their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a report on Friday, August 22nd. Seven analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Healthpeak Properties presently has an average rating of “Moderate Buy” and an average price target of $20.82.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.